Journal Image
Endocrine, Metabolic & Immune Disorders-Drug Targets
(Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders)
ISSN (Print): 1871-5303
ISSN (Online): 2212-3873
DOI: 10.2174/1871530313666131224114530      Price:  $58

Hereditary Rickets. How Genetic Alterations Explain the Biochemical and Clinical Phenotypes

Author(s): Anna Papadopoulou, Evaggelia Gole and Polyxeni Nicolaidou
Pages 324-334 (11)
The reemergence of vitamin D deficiency in the industrialized countries resurrects the “threat” of nutritional rickets, especially among pediatric populations, a fact that may lead to underdiagnosis of hereditary rickets. Today, hereditary rickets may be subdivided into two main groups according to their biochemical profile: the one associated with defects in vitamin D synthesis and action and the second associated with abnormal phosphorus metabolism. The classification of the patients in a particular group of hereditary rickets is determinative of the treatment to follow. This review, through the recent advances on vitamin D and P metabolism, discusses the molecular and biochemical defects associated to each group of inherited rickets, as well as the clinical phenotypes and the recommended therapeutic approaches.
FGF23, Klotho, Phosphorus, Rickets, Vitamin D, VDR.
3rd Department of Pediatrics, Medical School, University of Athens, University General Hospital Attikon, 1, Rimini Str, 12462 Athens, Greece.